North America Branded Generics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)

No. of Pages: 169    |    Report Code: BMIRE00026327    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Branded Generics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Branded Generics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Branded Generics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Adoption of Branded Generics owing to their Affordability to Favor Market
  • 5.1.2 Spurring government initiatives for the development of branded generics augmenting the market growth
5.2 Market Opportunities
  • 5.2.1 Loss of Patent Exclusivity of Branded drugs and Emergence of Biosimilars Brings Future Opportunities
5.3 Future Trends
  • 5.3.1 Utilization of Branded Generics by Healthcare Providers and Professionals
5.4 Impact of Drivers and Restraints

6. North America Branded Generics Market Regional Analysis

6.1 North America Branded Generics Market Overview
6.2 North America Branded Generics Market Revenue 2020-2028 (US$ Billion)
6.3 North America Branded Generics Market Forecast Analysis

7. North America Branded Generics Market Analysis – by Therapeutic Application

7.1 Oncology
  • 7.1.1 Overview
  • 7.1.2 Oncology: North America Branded Generics Market – Revenue and Forecast to 2031 (US$ Billion)
7.2 Cardiovascular Diseases
  • 7.2.1 Overview
  • 7.2.2 Cardiovascular Diseases: North America Branded Generics Market – Revenue and Forecast to 2031 (US$ Billion)
7.3 Diabetes
  • 7.3.1 Overview
  • 7.3.2 Diabetes: North America Branded Generics Market – Revenue and Forecast to 2031 (US$ Billion)
7.4 Neurology
  • 7.4.1 Overview
  • 7.4.2 Neurology: North America Branded Generics Market – Revenue and Forecast to 2031 (US$ Billion)
7.5 Gastrointestinal Diseases
  • 7.5.1 Overview
  • 7.5.2 Gastrointestinal Diseases: North America Branded Generics Market – Revenue and Forecast to 2031 (US$ Billion)
7.6 Dermatology Diseases
  • 7.6.1 Overview
  • 7.6.2 Dermatology Diseases: North America Branded Generics Market – Revenue and Forecast to 2031 (US$ Billion)
7.7 Analgesics & Anti-Inflammatory
  • 7.7.1 Overview
  • 7.7.2 Analgesics & Anti-Inflammatory: North America Branded Generics Market – Revenue and Forecast to 2031 (US$ Billion)

8. North America Branded Generics Market Analysis – by Distribution Channel

8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Hospitals: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.2 Retail Pharmacies
  • 8.2.1 Overview
  • 8.2.2 Retail Pharmacies: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.3 Online Pharmacies
  • 8.3.1 Overview
  • 8.3.2 Online Pharmacies: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.4 Drug Stores
  • 8.4.1 Overview
  • 8.4.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9. North America Branded Generics Market Analysis – by Drug Class

9.1 Alkylating Agents
  • 9.1.1 Overview
  • 9.1.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.2 Antimetabolites
  • 9.2.1 Overview
  • 9.2.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.3 Hormones
  • 9.3.1 Overview
  • 9.3.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.4 Antihypertensive
  • 9.4.1 Overview
  • 9.4.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.5 Lipid-Lowering Drugs
  • 9.5.1 Overview
  • 9.5.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.6 Antidepressants
  • 9.6.1 Overview
  • 9.6.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.7 Antipsychotics
  • 9.7.1 Overview
  • 9.7.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.8 Antiepileptic
  • 9.8.1 Overview
  • 9.8.2 Drug Stores: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10. North America Branded Generics Market – North America Analysis

10.1 North America
  • 10.1.1 North America Branded Generics Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Branded Generics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
    • 10.1.1.1.1 US: North America Branded Generics Market Breakdown, by Therapeutic Application
    • 10.1.1.1.2 US: North America Branded Generics Market Breakdown, by Distribution Channel
    • 10.1.1.1.3 US: North America Branded Generics Market Breakdown, by Drug Class
  • 10.1.1.2 Canada: North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
    • 10.1.1.2.1 Canada: North America Branded Generics Market Breakdown, by Therapeutic Application
    • 10.1.1.2.2 Canada: North America Branded Generics Market Breakdown, by Distribution Channel
    • 10.1.1.2.3 Canada: North America Branded Generics Market Breakdown, by Drug Class
  • 10.1.1.3 Mexico : North America Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
    • 10.1.1.3.1 Mexico : North America Branded Generics Market Breakdown, by Therapeutic Application
    • 10.1.1.3.2 Mexico : North America Branded Generics Market Breakdown, by Distribution Channel
    • 10.1.1.3.3 Mexico : North America Branded Generics Market Breakdown, by Drug Class

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Branded Generics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Aspen Holdings
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 AstraZeneca
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Bausch Health (Valeant Pharmaceuticals)
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Dr. Reddy's Laboratories Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 GlaxoSmithKline plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Hetero
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Lupin
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Mylan N.V.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Par Pharmaceuticals
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Sandoz International Gmbh
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Sanofi
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Teva Pharmaceutical Industries Ltd.
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Branded Generics Market

  1. Aspen Holdings
  2. AstraZeneca
  3. Bausch Health (Valeant Pharmaceuticals)
  4. Dr. Reddy's Laboratories Inc.
  5. GlaxoSmithKline plc
  6. Hetero
  7. Lupin
  8. Mylan N.V.
  9. Par Pharmaceuticals
  10. Sandoz International Gmbh
  11. Sanofi
  12. Teva Pharmaceutical Industries Ltd.
north-america-branded-generics-market